Those results were driven by, among other factors, strong surgical growth at its ASC business, United Surgical Partners International, Tenet said in a Feb. 1 news release.
“Our team continues to deliver consistently strong results, driven by Tenet’s data-driven and disciplined operating model,” Tenet CEO Saum Sutaria, MD, said in the release.
Tenet will release its fourth-quarter and full-year earning results Feb. 8.
The health system’s adjusted EBITDA for 2022 was $3.47 billion. Tenet said in its Oct. 30 quarterly earnings report that it increased its adjusted EBITDA outlook for 2023 to be in the range of $3.37 billion to $3.47 billion.
